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Abstract
Background: Primary osteosarcoma of the breast is an extremely rare lesion. The pathogenesis of primary
osteosarcomas is controversial.
Case presentation: We present the case of a 63-year-old white German woman who presented with a mass in
her right breast after routine screening. The core needle biopsy showed ductal hyperplasia with metaplastic
ossification of the breast tissue. Complete excision of the lesion with standard safety margins was performed. The
final diagnosis was metaplastic ossification. Three years later, our patient presented again with a painless lump in
her right breast about 15 × 8 × 7 cm, extending to the lower part of axilla with skin ulceration. Pathologic
diagnosis was osteosarcoma. Positron emission tomography and computed tomography and staging showed no
other lesions. Modified radical mastectomy and axillary lymph node dissection was performed, no lymph node
metastases were found.
Conclusions: Our case highlights the possibility that primary osteosarcoma of the breast may develop after
complete resection with the classical safety margin for metaplastic ossification. Long-term follow-up after
resection of this benign breast lesion is required.
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Background
Breast sarcomas are very uncommon and make up less
than 1 % of all primary breast malignancies. Primary
osteosarcoma accounts for about 12.5 % of all breast
sarcomas.
The histogenesis of primary osteosarcoma of the
breast is unknown, prognosis and optimal treatment re-
main uncertain because of the rarity of this tumor. Pub-
lished data consist almost exclusively of single case
reports, with one major series [1]. More data and infor-
mation regarding this rare tumor are highly needed. We
present a rare case of primary osteosarcoma that devel-
oped 3 years after complete resection with the safety
margin of metaplastic ossification.
Case presentation
A 63-year-old white German woman presented with a
lump in her right breast following routine screening for
breast cancer.
Screening mammography demonstrated a very dense
calcified 35-mm lobular mass in her medial right breast.
An ultrasound scan showed an irregular lesion 11.1 ×
20.1 mm (Fig. 1).
A clinical examination of her breast revealed a
golf-ball-sized mass located at the 6–9-o’clock
position in her right breast, arterial hypertension,
otherwise no other symptoms or neurological deficits
were present.
Intervention: in July 2009, a core needle biopsy of
the lesion was performed, histologically showing
ductal hyperplasia with metaplastic ossification of
breast tissue. No malignant tissue was detected. The
specimens were examined by two different patholo-
gists of two different institutes. As differential
diagnosis, a metaplastic carcinoma was considered.
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Complete excision was recommended by the path-
ologist. In October 2009, complete excision of the
lesion with standard safety margins was performed.
The diagnosis was metaplastic ossification. Again
Figs. 2 and 3, the specimen was examined by two
different pathologists. No postoperative therapy was
recommended. Follow-up examinations at intervals
of 3–6 months were recommended; after 2 years of
uneventful follow-up further examinations were re-
fused by our patient.
One year later our patient presented again with a
lump in her right breast about 150 × 80 × 70 mm,
extending to the lower part of the axilla with skin ul-
ceration. Positron emission tomography and com-
puted tomography (PET-CT) and staging showed no
further metastases (Fig. 4).
Pathological examination: the tumor specimen was
fixed in 4 % phosphate-buffered formalin and routinely
paraffin-embedded. Sections 4 μm thick were stained
with hematoxylin and eosin as well as Elastica van
Gieson.
Moreover they were immunostained with the avidin
biotin-peroxidase complex method using the following
antibodies: anti-high molecular epithelial marker
(cytokeratins: ck 5/6 and ck pan: AE 1/3), anti-EMA
(cytomed, 1:100).
Immunohistochemically, the tumor did not express
any epithelial tissue markers at all. Anti-EMA reaction
showed no gland development in the tumor mass.
The case with all specimens went again to Canada for
a second opinion (Figs 5 and 6). The first diagnosis had
been confirmed. No further pathological examination
was planned.
Surgery and postoperative follow-up: in November
2012, modified radical mastectomy and axillary
lymph node dissection were performed, no lymph
node metastases were found. Postoperative chemo-
therapy followed. PET-CT and staging showed no
evidence of metastatic or recurrent disease. One year
after surgery our patient died of complications due
to lung metastases and pleural effusion.
Discussion
Primary osteosarcomas of the breast are extremely rare
lesions with few published data. Histogenesis, progno-
sis and optimal treatment of primary osteosarcoma re-
main uncertain [1], and is controversial; an origin from
normal breast tissue de novo or as osseous metaplasia
Fig. 1 a Sonographic picture of the breast showing an irregular lesion, 11.1 × 20.1 mm. b Mammography showed a calcified prepectoral fine delimited mass
Fig. 2 a Computed tomography scan of the chest demonstrates a calcifying tumor mass of the right breast. No other tumor in chest or elsewhere
was seen. b Scintigraphy shows a huge tumor in the right breast with calcification areas. No others tumors at the bone site were seen
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in a pre-existing benign or malignant neoplasm of the
breast or as non-phylloides sarcoma has been sug-
gested [2, 3].
Primary osteosarcoma should be diagnosed only after
metaplastic mammary carcinoma is ruled out. However,
metaplastic carcinoma shows an epithelial differentiation.
Therefore, it is essential to examine a major number of
tumor tissue blocks, also by means of immunohistochem-
istry [1]. In our case, the tumor showed neoplastic bone
and cartilage formation with no evidence of epithelial dif-
ferentiation. The pathological examination was performed
both in Germany and in Canada.
The primary osteosarcoma presented here devel-
oped in breast tissue following surgical removal of
Fig. 3 a in the middle of the picture newly formed bone trabeculae with delimited fat tissue on the right and fibrous tissue on the left. Core biopsy,
Hematoxylin and eosin, 60×. b Magnification of Fig. 3a showing benign bone tissue with an example of a trabecula in the middle surrounded by
osteoclasts to the right and osteoblasts to the left. In between osteocytes, no evidence of malignancy. Hematoxylin and eosin,100×
Fig. 4 a-d Excision specimen, histological pictures. a Benign lesion after the core biopsy has been gained. The resorptive connective
tissue to the left is seen. Hematoxylin and eosin, 40×. b and c: like (a). Hematoxylin and eosin, 60×. d Tumor-free resection margin. The
ink is seen at the bottom. Hematoxylin and eosin, 10×
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the metaplastic ossification with safety margins,
which microscopically were found to be tumor-free.
Based on the existing data, we may presume that the
primary osteosarcoma described here arose from
normal breast tissue, but the presence of the previ-
ously completely excised metaplastic ossification
makes it difficult to prove this assumption. Our case
report is in agreement with previously published
data [4–7].
Our case highlights the importance of close follow-
ups in cases of benign breast lesions such as
metaplastic ossifications. Primary osteosarcoma should
be included routinely in the differential diagnosis of
breast tumors. Initially, our patient had clinically been
diagnosed as having breast carcinoma. In almost every
case in the literature, the diagnosis of primary osteo-
carcoma was established histologically [8].
Primary osteosarcoma of the breast occurs in a wide
range of age, from 12 to 89 years, predominantly in
middle-aged and older women [1, 2]. The tumors vary
in size up to maximum diameters of 30 cm and may be
smooth or lobulated, solid or cystic, freely mobile or
fixed and occasionally ulcerated. No specific clinical
features reliably distinguish it from other malignant
breast tumors [1].
Breast osteosarcomas are highly malignant, most patients
dying within 2 years. It spreads mainly by the
hematogenous route and axillary nodes are rarely involved.
Tumor response to adjuvant chemotherapy is unclear.
Surgery remains the most favored therapy, some authors
recommend simple mastectomy as the treatment of choice,
as wide local excision may be complicated by early local re-
currence [9]. However, others recommend a wide surgical
excision of the tumor without axillary node dissection [1].
Adjuvant radiotherapy is recommended as an addition to
the treatment, although no standard of care for these le-
sions has been made [10].
Conclusions
It is important to be aware of this unusual occurrence
and to differentiate it from metaplastic carcinoma, as
well as from malignant phylloides tumor, as it has a dif-
ferent behavior and prognosis.
Fig. 5 a Macroscopy of an osteosarcoma of the breast. Yellowish destructive aggressive growth of the tumor ulcerating the skin. Alveolar bone
formation seen at the bottom, in the middle and at the upper right of the picture. b Histology osteosarcoma of the breast in whole scale image.
Hematoxylin and eosin, 1×
Fig. 6 a Aggressive tumor cells destroying the connective tissue between the trabeculae of the bone tumor. Hematoxylin and eosin, 60×.
b Magnification of tumor cells and trabeculae of the bone tissue as demonstrated in Fig. 6a Hematoxylin and eosin, 100×
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